Reference 5 - Dabrafenib hard capsule 50 and 75 mg product-specific bioequivalence guidance
FDA-2026-P-6541-0007Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Reference 5 - Dabrafenib hard capsule 50 and 75 mg product-specific bioequivalence guidance
- Posted
- Jun 9, 2026
- Topics